Loneliness and Occurrence of Suicide Attempts and Suicidal Ideas
NCT ID: NCT02829671
Last Updated: 2022-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
600 participants
INTERVENTIONAL
2016-10-11
2020-06-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main objective is the study of the relationship between loneliness and the occurrence of suicidal behavior (SB) in major depressed adult population over 12 months.
The secondary objectives are:
* Identification of risk factors (clinical, neuropsychological and biological) of the occurrence of SB within a clinical population and their interaction;
* Identification of predictive factors (clinical, neuropsychological, biological) therapeutic response to antidepressant in the context of depression.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predictors of Suicidal Behavior in Depression
NCT02904005
Predictive Nature of Total Cholesterol Threshold: Possible Link to Suicidal Behavior
NCT02847741
Characterization of Suicidal Depression
NCT05046587
Neuroinflammation, Serotonin, Impulsivity and Suicide
NCT02824081
Neuropsychological Factors Associated With Vulnerability to Suicidal Behavior in Depressed Elderly Patients
NCT02737540
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Over three years, 600 depressed patients will be recruited.
* First visit (inclusion): clinical, biological and neuropsychological assessment
* Follow up visits (3, 6 and 12 months): clinical assessment only
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with major depressive disorders
Clinical and biological assessment
Blood sample, clinical assessment with questionnaires
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Clinical and biological assessment
Blood sample, clinical assessment with questionnaires
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016- -A00276-45
Identifier Type: OTHER
Identifier Source: secondary_id
UF 9702
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.